Induction of Apoptosis and Cytotoxicity by Isothiocyanate Sulforaphene in Human Hepatocarcinoma HepG2 Cells
10.3390/nu10060718 · doi-reference
Snake Venom Causes Apoptosis by Increasing the Reactive Oxygen Species in Colorectal and Breast Cancer Cell Lines
10.2147/ott.s115055 · doi-reference
A Leucine Zipper Motif in the Ectodomain of Sendai Virus Fusion Protein Assembles in Solution and in Membranes and Specifically Binds Biologically‐Active Peptides and the Virus
10.1021/bi971152i · doi-reference
Aggregation and Organization of Pardaxin in Phospholipid Membranes. A Fluorescence Energy Transfer Study
10.1016/s0021-9258(19)50456-2 · doi-reference
Proteolytically Stable Cyclic Decapeptide for Breast Cancer Cell Targeting
10.1021/acs.jmedchem.7b00163 · doi-reference
Common and Cell‐Type Specific Responses to Anti‐Cancer Drugs Revealed by High Throughput Transcript Profiling
10.1038/s41467-017-01383-w · doi-reference
Biophysics in Cancer: The Relevance of Drug‐Membrane Interaction Studies
10.1016/j.bbamem.2016.06.025 · doi-reference
Antimicrobial Peptides and Their Use in Medicine
10.1134/s0003683810090012 · doi-reference
Peptide‐Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria
10.1021/acs.accounts.6b00277 · doi-reference
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
10.3390/ijms20102383 · doi-reference
Activation of Apoptosis In Vivo by a Hydrocarbon‐Stapled BH3 Helix
10.1126/science.1099191 · doi-reference
Anti‐Cancer Activity of Targeted Pro‐Apoptotic Peptides
10.1038/12469 · doi-reference
Novel Anti‐Angiogenic Peptides Derived From ELR‐Containing CXC Chemokines
10.1002/jcb.21712 · doi-reference
Anti‐Angiogenic Peptides for Cancer Therapeutics
10.2174/138920111796117300 · doi-reference
Antimicrobial Peptide Moricin Induces ROS Mediated Caspase‐Dependent Apoptosis in Human Triple‐Negative Breast Cancer via Suppression of Notch Pathway
10.1186/s12935-023-02958-y · doi-reference
Induction of G1‐Phase Cell Cycle Arrest and Apoptosis Pathway in MDA‐MB‐231 Human Breast Cancer Cells by Sulfated Polysaccharide Extracted From Laurencia papillosa
10.1186/s12935-016-0315-4 · doi-reference
Six‐Transmembrane Epithelial Antigen of the Prostate 1 Protects Against Increased Oxidative Stress via a Nuclear Erythroid 2‐Related Factor Pathway in Colorectal Cancer
10.1038/s41417-018-0056-8 · doi-reference
Activation of Apoptosis Signalling Pathways by Reactive Oxygen Species
10.1016/j.bbamcr.2016.09.012 · doi-reference
Mitochondrial ROS and Cancer Drug Resistance: Implications for Therapy
10.1016/j.phrs.2015.06.013 · doi-reference
Physiological Roles of Mitochondrial Reactive Oxygen Species
10.1016/j.molcel.2012.09.025 · doi-reference
Reactive Oxygen Species in Cancer
10.3109/10715761003667554 · doi-reference
Sphingomyelin and Sphingomyelin Synthase (SMS) in the Malignant Transformation of Glioma Cells and in 2‐Hydroxyoleic Acid Therapy
10.1073/pnas.1115484108 · doi-reference
Increased Exposure of Phosphatidylethanolamine on the Surface of Tumor Vascular Endothelium
10.1593/neo.101366 · doi-reference
Asymmetric Distribution of Phospholipids in Biomembranes
10.1248/bpb.29.1547 · doi-reference
On the Importance of Electrostatic Interactions Between Cell Penetrating Peptides and Membranes: A Pathway Toward Tumor Cell Selectivity?
10.1016/j.biochi.2014.07.022 · doi-reference
Discovery of Novel Tumor‐Targeting Peptide‐Oncolytic Peptide Based Conjugates (PPCs): A New Paradigm for Targeted Oncolytic‐Immunotherapy
10.1016/j.apsb.2026.01.006 · doi-reference
Curved Plane Increases the d Vacancy Population of Pd for Green Production of Cyclohexanone
10.1016/j.chempr.2024.03.022 · doi-reference
Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics
10.1007/s10989-023-10524-3 · doi-reference
Combination of Aspartic Acid and Glutamic Acid Inhibits Tumor Cell Proliferation
10.2220/biomedres.37.153 · doi-reference
Improving the Cell Permeability of Polar Cyclic Peptides by Replacing Residues With Alkylated Amino Acids, Asparagines, and d‐Amino Acids
10.1021/acs.orglett.7b03363 · doi-reference
Design of Potent, Non‐Toxic Anticancer Peptides Based on the Structure of the Antimicrobial Peptide, Temporin‐1CEa
10.1007/s12272-013-0112-8 · doi-reference
Investigation of Cytotoxicity of Negative Control Peptides Versus Bioactive Peptides on Skin Cancer and Normal Cells: A Comparative Study
10.4155/fmc.12.98 · doi-reference
Induction of Tumor Cell Autosis by Myxoma Virus‐Infected CAR‐T and TCR‐T Cells to Overcome Primary and Acquired Resistance
10.1016/j.ccell.2022.08.001 · doi-reference
Metabolic Signatures Associated With Oncolytic Myxoma Viral Infections
10.1038/s41598-022-15562-3 · doi-reference
Oncolytic Virotherapy With Myxoma Virus
10.3390/jcm9010171 · doi-reference
Therapy With Oncolytic Viruses: Progress and Challenges
10.1038/s41571-022-00719-w · doi-reference
